Long-term complications after liver transplantation.

No abstract is available for this paper.

• Publication year

  2014

• Venue

  Transplantation Proceedings

• Publication date

  2014-04-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/j.transproceed.2013.11.047PMID 24767352
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Part I

  2019cited by this paper
• 非アルコール性脂肪肝炎の治療薬およびバイオマーカーの開発における課題と機会 : 米国肝臓病学会(American Association for the Study of Liver Diseases)と米国食品医薬品局の合同ワークショップの知見と推奨

  2015cited by this paper
• Long‐term outcome of ‘long‐term liver transplant survivors’

  2013cited by this paper
• Diabetes, Hypertension and Hyperlipidemia: Prevalence Over Time and Impact on Long‐Term Survival After Liver Transplantation

  2012cited by this paper
• Metabolic syndrome in liver transplant recipients: Prevalence, risk factors, and association with cardiovascular events

  2011cited by this paper
• Reduced‐Dose Tacrolimus with Mycophenolate Mofetil vs. Standard‐Dose Tacrolimus in Liver Transplantation: A Randomized Study

  2011cited by this paper
• Early Changes in Kidney Function Predict Long-Term Chronic Kidney Disease and Mortality in Patients After Liver Transplantation

  2011cited by this paper
• Predicting Renal Failure After Liver Transplantation From Measured Glomerular Filtration Rate: Review of up to 15 Years of Follow-Up

  2010cited by this paper
• Delayed Introduction of Reduced‐Dose Tacrolimus, and Renal Function in Liver Transplantation: The ‘ReSpECT' Study

  2009cited by this paper
• Long‐term renal function in liver transplant recipients and impact of immunosuppressive regimens (calcineurin inhibitors alone or in combination with mycophenolate mofetil): The TRY study

  2009cited by this paper
• Long‐term results after liver transplantation

  2008cited by this paper
• Mycophenolate mofetil in combination with reduction of calcineurin inhibitors for chronic renal dysfunction after liver transplantation

  2006cited by this paper
• Coronary event rates in liver transplant recipients reflect the increased prevalence of cardiovascular risk‐factors

  2005cited by this paper
• Metabolic syndrome.

  2005cited by this paper
• 2003 World Health Organization (WHO)/International Society of Hypertension (ISH) statement on management of hypertension

  2003cited by this paper
• National Kidney Foundation Practice Guidelines for Chronic Kidney Disease: Evaluation, Classification, and Stratification

  2003influential reference
• Identification of patients best suited for combined liver–kidney transplantation: Part II

  2002cited by this paper
• Chronic renal dysfunction late after liver transplantation

  2002cited by this paper
• Pathophysiology of renal disease associated with liver disorders: Implications for liver transplantation. Part I

  2002cited by this paper
• De novo malignancies after liver transplantation: A major cause of late death

  2001cited by this paper
• Replacement of calcineurin inhibitors with mycophenolate mofetil in liver-transplant patients with renal dysfunction: a randomised controlled study.

  2001cited by this paper
• Improvement of acute and chronic renal dysfunction in liver transplant patients after substitution of calcineurin inhibitors by mycophenolate mofetil.

  2000cited by this paper
• RIGHT LOBE GRAFT IN LIVING DONOR LIVER TRANSPLANTATION 1,2

  2000cited by this paper
• Long-term medical complications in patients surviving > or = 5 years after liver transplant.

  2000cited by this paper
• Liver transplantation

  2000cited by this paper
• Right lobe graft in living donor liver transplantation.

  1999cited by this paper
• Chronic renal failure following liver transplantation: a retrospective analysis.

  1998cited by this paper
• Liver transplantation in children from living-related donors.

  1993cited by this paper
• American association for the study of liver diseases

  1992cited by this paper
• Liver transplantation in children from living related donors. Surgical techniques and results.

  1991cited by this paper
• A Retrospective Analysis

  1990cited by this paper
• De novo malignancies after liver transplantation.

  1988cited by this paper
• A simple estimate of glomerular filtration rate in children derived from body length and plasma creatinine.

  1976cited by this paper
• HOMOTRANSPLANTATION OF THE LIVER IN HUMANS.

  1963cited by this paper

• Metabolic Disorders in Liver Transplant Recipients: The State of the Art

  2024cites this paper
• Quality of life 5 years following liver transplantation

  2021cites this paper
• A comparison of rates and severity of chronic kidney disease in deceased-donor and living-donor liver transplant recipients: times matter

  2020cites this paper
• Vascular and Biliary Complications Following Deceased Donor Liver Transplantation: A Meta-analysis.

  2019cites this paper
• Risk factors for arterial hypertension after liver transplantation.

  2018cites this paper
• Intracranial hemorrhage induced uncontrolled seizure in a deceased donor liver transplant patient: a case report

  2016cites this paper
• Role of Different Types of MELD Sore in Prediction of Short-Term Morbidity and Mortality after Living Donor Liver Transplantation : A Single Center Experience in Egypt

  2016cites this paper
• Complications and mortality after adult to adult living donor liver transplantation: A retrospective cohort study

  2015cites this paper
• Comparing 10‐yr renal outcomes in deceased donor and living donor liver transplants

  2015cites this paper
• Murine-Derived ABO Incompatability in Liver Transplantation

  2014cites this paper
• ABO Incompatability in Liver Transplantation

  2014cites this paper